The BioScience Grants program was established to foster advances in scientific research and medical education. With an emphasis on the patient as a priority, the Grants Program is designed to support novel therapeutic discoveries. The BioScience Grants team oversees the review, award, and progress of investigator initiated research and medical education grants from around the world. The Grants Team works closely with the regional and global Medical Affairs teams and cross functional resources in Hemophilia, BioTherapeutics, and BioSurgery, to critically assess each grant request. Grant proposals demonstrating exceptional scientific merit and therapeutic alignment are given priority for funding and product awards.
The value of our program is measured with the deliverables from each activity we support. For medical education programs this is the educational assessment completed by program attendees. For investigator initiated studies the deliverable is the final study report, manuscript or abstract submitted for publication.
In 2012 our program awarded more than $9 million in grants supporting investigator-initiated research and medical education initiatives.
We encourage investigators and other requestors to submit applications for funding to help expand the body of scientific knowledge to benefit healthcare practitioners and their patients worldwide.
Our areas of interest are constantly evolving; potential applicants with additional questions are encouraged to contact a member of our Global Clinical and Medical Affairs staff to discuss our grant program initiatives.
To learn more about Baxter's BioScience business, please visit the Baxter website.
Together, we can make a difference in patients’ lives.
Download the latest version of our brochure for Investigator Initiated Research Studies.